Nitric oxide (NO) is a gaseous molecule with neurotransmitter properties that is involved in numerous functions in the central nervous system (CNS), the vascular system and also in macrophages. Haplotypes of NOS1 and NOS3 genes have been shown to be associated with different psychiatric disorders such as schizophrenia and bipolar disorder. Therefore, the detection of other characteristics of nitrinergic transmission is desirable. Because nitrinergic functioning influences serotonergic transmission, a functional marker of the serotonergic transmission, the loudness dependence of auditory evoked potentials (LDAEP), can be assumed to be influenced by nitrinergic changes as well. In order to clarify the relationship between nitrinergic transmission and LDAEP, 95 healthy subjects (41 males, 54 females) underwent electrophysiological recording and blood drawing for genotyping of single nucleotide polymorphisms (SNPs) and haplotypes of the NOS1 and NOS3 genes. Interestingly, two functional SNPs in both NOS1 (G-84A_exon 1c promoter polymorphism) and NOS3 (Glu298Asp) were associated with lower LDAEP. Further studies are needed to fully clarify the relationship between nitrinergic transmission, LDAEP and complex disorders such as schizophrenia and affective disorders.
Introduction
Nitric oxide (NO) is a gaseous molecule with neurotransmitter properties that is involved in numerous functions in the central nervous system (CNS), the vascular system and also in macrophages (Snyder and Ferris, 2000 ; Yun et al., 1997) . Unlike other neurotransmitters, NO is not stored in vesicles and thus must be generated when release is required. A manifold interaction between NO and serotonin has been reported by different animal studies : NO signalling modulates serotonin release (Iuras et al., 2005 ; Prast and Philippu, 2001 ; Segieth et al., 2001 ; Smith and Whitton, 2000 ; Trabace and Kendrick, 2000) , it enhances the post-synaptic serotonin response (Straub et al., 2007) , and affects the reuptake of serotonin (Bryan-Lluka et al., 2004 ; Kilic et al., 2003) . Additionally, interactions with serotonin reuptake inhibitors (Harkin et al., 2003 (Harkin et al., , 2004 Inan et al., 2004) and modulations of 5-HT 1 receptors (Chiavegatto and Nelson, 2003 ; Pitsikas et al., 2005) have been reported.
Furthermore, a recent paper by Chanrion et al. (2007) was able to show that the neuronal nitric oxide synthase (nNOS) interacts with the C terminus of the serotonin transporter (SERT) and that co-expression of nNOS and SERT in HEK293 cells decreased SERT cell surface localization and serotonin uptake.
NO dynamics are determined by nitric oxide synthase (NOS) activity (Snyder and Ferris, 2000) . NOS catalyses the synthesis of NO from the amino acid L-arginine in an enzymatic reaction with nicotinamide adenine nucleotide phosphate (NADPH) as a co-factor. Three isoforms of the enzyme have been purified, nNOS or NOS-I, the neuronal form ; iNOS or NOS-II, the macrophage form ; and eNOS or NOS-III, the endothelial form. NOS-I and NOS-III are involved in CNS neurotransmission.
NOS-I forms the main source on NO in excitable tissues, it can be found in 1 % of all neurons (Snyder and Ferris, 2000) . As revealed by immunohistochemical and autoradiographic studies, the distribution of NOS-I achieves its maximum in the cerebellum followed by the hippocampus and neocortex (Bredt and Snyder, 1989 ; Kidd et al., 1995) . Another enzyme influencing NO function in the brain is the endothelial nitric oxide synthase (NOS-III) (Reif et al., 2006b ). Mice lacking NOS-III show a low rate of neural stem cell proliferation, and in an animal model of depression, i.e. the learned helplessness paradigm, those mice show a poorer responsiveness (Reif et al., 2004) . NOS-III is expressed in the endothelium of the CNS and has been hypothesized to also be present in neurons such as the CA1 pyramidal cells Doyle and Slater, 1997 ; O'Dell et al., 1994) .
NOS1 and NOS3 haplotypes have been shown to be associated with different psychiatric disorders such as schizophrenia, bipolar disorder (Reif et al., 2006a,b) and suicidal behaviour (Rujescu et al., 2007) making them candidate genes of considerable interest.
Due to its gaseous properties, N-functioning itself is not easily detectable in vivo. Another marker of NO functioning, i.e. NOS enzyme activity, is also not easily determinable, especially in humans. Due to its close interactions with the serotonergic system, a marker of the serotonergic activity may provide more insight in human nitrinergic neurotransmission. The loudness dependence of auditory evoked potentials (LDAEP) is widely used as a well established and reliable measure of central serotonergic activity (Hegerl et al., 2001 ; Hegerl and Juckel, 1993 Juckel et al., 1996) . LDAEP is the change in amplitude of auditory evoked potentials in response to different stimulus intensities. The inverse relationship between LDAEP and central serotonergic activity has been shown by different methods. LDAEP has been compared to direct serotonin markers such as 5-hydroxyindolacetic acid (5-HIAA) in the cerebrospinal fluid in humans (von Knorring and Perris, 1981) and in animal models (Ehlers et al., 1991 ; Pineda et al., 1991) . In awake cats, microinjection of the 5-HT 1A agonist 8-OH-DPAT into the dorsal raphe nuclei inhibits the firing rate of serotonergic neurons via an autoreceptor feedback loop. This has been shown to cause a higher loudness dependence in recordings from the primary auditory cortex (Juckel et al., 1999) , an area underlying dense serotonergic innervation with fibres from the dorsal raphe nuclei (Jacobs and Azmitia, 1992 ; Lewis et al., 1986) . LDAEP changes have also been found in different psychiatric disorders such as depression, schizophrenia, obsessive-compulsive disorder and alcohol dependency (Chen et al., 2005 ; Hegerl et al., 1996 ; Juckel et al., 2003 ; Pogarell et al., 2004) .
Thus, modifications in nitrinergic transmission may be accompanied by altered LDAEP via nitrinergicserotonergic interaction.
An interrelation of nitrinergic transmission with LDAEP as a marker of serotonergic transmission might be detectable by genetic association. Subjects carrying NOS1 and NOS3 variants influencing nitrinergic transmission may exhibit loudness dependence differences compared to subjects without these specific polymorphisms.
Materials and methods

Subjects
Unrelated healthy volunteers of German descent (i.e. both parents German) were randomly selected from the general population of Munich, Germany, and contacted by mail. To exclude subjects with neuropsychiatric disorders or subjects who had firstdegree relatives with neuropsychiatric disorders, we conducted further screenings before the volunteers were enrolled in the study. First, subjects who responded were initially screened by phone. Detailed medical and psychiatric histories were assessed for both themselves and their first-degree relatives by using systematic forms. Second, they were invited to a comprehensive interview including the Structured Clinical Interview for DSM-IV (SCID I and SCID II) (First et al., 1997 ; Wittchen et al., 1997) to evaluate their lifetime Axis I and II disorders. Psychiatric diagnoses among their first-degree relatives were also assessed using the Family History Assessment Module (Rice et al., 1995) . Subjects with relevant somatic diseases or hearing problems (objectified by standardized 1000 Hz tone audiometry) or a lifetime history of any Axis I or II psychiatric disorders were excluded. Subjects who had first-degree relatives with a lifetime history of a mental disorder were also excluded. Finally, 95 healthy subjects (41 males, 54 females) were included that underwent electrophysiological recording and blood drawing for genotyping. Their mean age was 43¡15 yr (range 19-72 yr). In total, 26.3 % had attained a low educational level, 25.3 % a middle and 48.4 % a high educational level. The study was approved by the ethics committee of the LudwigMaximilians-University of Munich. All subjects gave written informed consent.
Genotyping
Genotyping of all 55 single nucleotide polymorphisms (SNPs) was performed using the following methods. Seven SNPs (NOS1 : rs2682826, rs1353939, rs693534, rs2293049 ; NOS3 : rs2070744, rs1799983, rs891512) were genotyped by Illumina (Illumina Inc., San Diego, CA, USA) using their Integrated BeadArray System. We supplied Illumina with bar-coded DNA microtitre plates containing the DNA quantified with Pico Green to be at 100 ng/ml and Illumina delivered genotypes with a quality score calculated by proprietary Illumina algorithms. A further 17 SNPs were genotyped at the Genetics Research Centre (GRC) using iPLEX assays on the MassARRAY MALDI-TOF mass spectrometer (Sequenom, Hamburg, Germany). SNPs were selected from the NCBI SNP database (http://www.ncbi.nlm. nih.gov) and 'Tagger ' (http://www.broad.mit.edu/ mpg/tagger/server.html). Only validated SNPs with a minor allele frequency of >1 % were selected.
Additionally, 31 SNPs in genes spanning all chromosomes were included as genomic controls (CLCA1, EDARADD, MYO3B, XDH, HRG, UBE1C, CORIN, GALNT7, BVES, ELOVL5, FGL2, ANXA13, XPO7, SH3GL2, AKR1CL2, LHPP, RAB30, RAG1, CD69, TEP1, ZFYVE21, OCA2, DC13, PELP1, CYB5, RAB31, BRUNOL5, RPS5, RIN2, MRPL39, HDAC10) and genotyped by Illumina. These genes were selected based on the low a-priori probability of involvement in behavioural traits and phenotypes.
Neurophysiological assessment
AEP recording (SynAmps Neuroscan 1 , El Paso, TX, USA) was performed with the patients' eyes open. Tones (1000 Hz, 40 ms duration, ISI 1800-2200 ms) of five intensities (60, 70, 80, 90, 100 dB SPL) were presented binaurally over headphones. At least 40 artifact-free (¡50 mV) sweeps/intensity were averaged. N1 peaks (60-125 ms) and P2 peaks (110-210 ms) were determined semi-automatically at Cz electrodes (linked mastoids reference). In order to reduce shortterm habituation effects, the first five responses to each intensity were rejected. The remaining sweeps (at least 40 per intensity) were averaged separately for each person and each intensity. N1 and P2 peaks were determined at the Cz electrode. The N1/P2 amplitude was defined as the difference between N1 and P2. The LDAEP was calculated as a linear regression slope with stimulus intensity as independent and N1/P2 amplitude as dependent variables. (For more details see Gallinat et al., 2000 ; Hegerl and Juckel, 1993 .)
Statistics
Haploview 3.2 was used to generate a linkage disequilibrium map and to test for Hardy-Weinberg equilibrium (Barrett et al., 2005) . Tests for associations using the multi-marker haplotypes were performed using the software environment ' R' (http://www.Rproject.org). Single haplotype significance and odds ratios were calculated as well as global significance. Permutation (10 000 permutations) was also used to estimate the global significance of the results for haplotype analyses and to validate the EM values. For comparison of loudness dependence values between haplotypes the 'R' package 'haplo.score ' was used (Schaid et al., 2002) . The following covariates were included into analysis : sex (t=x2.290, d.f.=93, p=0.024, with higher scores in females) and age (correlation : r=x0.246, p=0.016). The suite of R routines, referred to as 'haplo.score ', can be used to compute score statistics to test associations between haplotypes and a wide variety of traits, including binary, ordinal and quantitative traits. These methods assume that all subjects are unrelated and that haplotypes are ambiguous. The methods provide several different global and haplotype-specific tests for association, as well as adjustment for non-genetic covariates and computation of simulated p values (Schaid et al., 2002) . Single locus marker tests were also performed using analysis of variance (ANOVA) for LDAEP values at Cz controlled for the covariates sex, age and educational level if appropriate using SPSS 15.0 software (SPSS Inc., Chicago, IL, USA).
Results
As expected, none of the 31 SNPs in the genomic control genes showed an association with loudness dependence. One putative NOS1 SNP (rs2293049) was excluded from statistical analysis because it was not polymorphic in our sample. Two further NOS1 SNPs were excluded due to their deviation from the Hardy-Weinberg equilibrium (rs2682826, rs1353939).
The remaining 18 SNPs in NOS1 (Figure 1 ) and all SNPs in NOS3 were in Hardy-Weinberg equilibrium ( p>0.05). Figure 2 shows the linkage disequilibrium (LD) within NOS1. LD patterns for NOS3 show a weak to moderate LD (Dk=0.83) between two SNPs (rs1799983 and rs891512). 
NOS3
As the three remaining SNPs were either not in, or in weak to moderate, LD we did not perform haplotype analysis for NOS3. Interestingly, the only significant association was seen with a functional SNP (Glu298Asp ; rs1799983 ; allele : F=4.510, d.f.=1, 185, p=0.035) with the T (Asp) allele carrier showing lower LDAEP values.
Discussion and conclusion
We detected associations of two functional polymorphisms in NOS1 and NOS3 with a lower LDAEP. The findings support the hypothesis that the NO system may have an influence on LDAEP. A plausible explanation would be a modulation via serotonergic functioning. A low LDAEP has been shown to be an epiphenomenon of higher serotonergic activity (Juckel et al., 1997) . A subsequent change of LDAEP is plausible and supported by our findings. The -84A_ exon 1c SNP was associated with a 30 % decrease in NOS1 exon 1c expression levels (Saur et al., 2004) . Additionally, this SNP impacted on prefrontal functioning as assessed by neuropsychological testing and electrophysiological parameters (Reif et al., 2006a) .
The functional SNP in NOS3 which was associated with a lower LDAEP is localized in exon 8 and leads to an amino-acid exchange (Glu298Asp ; rs1799983). The consequences of different SNPs on NOS activity are unclear. In the case of lower LDAEP, lower NO functioning may be assumed, while the complex property of the serotonergic system and the incompletely clarified interaction on the cellular level must be taken into account.
One limitation of our study is the still incompletely clarified and presumably indirect interrelation between the modulating function of serotonin concerning LDAEP on one hand and properties of nitrinergic transmission on the other. Whether serotonin is the only neurotransmitter influencing LDAEP has been discussed (Juckel et al., 1997 ; O'Neill et al., 2006) , dopamine seems to be a promising influencing factor. Due to the influence of nitrinergic transmission on dopaminergic transmission (Reif et al., 2006a) , at least an additional interaction : nitrinergic transmission p dopaminergic transmission p serotonergic transmission is possible. Other limitations are the relatively low sample size and the possibility that unknown stratification biases may have not been taken into account. This is an association study, so causal connections between polymorphisms and LDAEP changes are unproven and can only be assumed.
In summary, LDAEP changes and also certain NOS1 and NOS3 polymorphisms have both been shown to be associated with psychiatric disorders such as schizophrenia and affective disorders (Reif et al., 2006a, b) and, according to our findings, LDAEP may be influenced by nitrinergic neurotransmission in humans via serotonergic changes influenced by NO. These novel findings warrant further replications including larger subject numbers. Moreover, further research including experimental changes in NO activity should be fruitful in elucidating the influence of nitrinergic transmission on LDAEP and on complex disorders subsequently.
